AbbVie

Glowing puzzle piece fitting into puzzle
Biotech

AbbVie pens $5.6B pact with RemeGen to join PD-1xVEGF race

AbbVie has made no secret of the fact that it's taken an interest in the hotly contested PD-1xVEGF bispecific space. Now, it's diving in.
James Waldron Jan 12, 2026 11:00am
holiday Christmas presents shopping cart

AbbVie, Gilead gift themselves clinical-stage cancer drugs

Jan 2, 2026 10:35am
Abstract modern white spiral clock dial with roman and arabic numerals

Aldeyra dry eye disease decision hit by FDA delay

Dec 16, 2025 11:55am
A ballpoint pen rests on top of a stack of documents ready for signing

AbbVie hands back phase 1 duties for inflammation drug to Ose

Dec 8, 2025 5:39am
Aerial view of Montreal Old Port in autumn

AbbVie seeks biotech applicants for Canadian innovation award

Nov 25, 2025 12:00pm
scissor cutting rope

AbbVie to end Calico collab, lay off scientists: Stat

Nov 13, 2025 3:59pm